Skip to main content
SpringerLink
Log in
Book cover

Zeitgemäße Therapie der erektilen Dysfunktion pp 13–101Cite as

Anatomie, Physiologie, Pathophysiologie

  • Chapter

  • 45 Accesses

Zusammenfassung

Voraussetzung für die Therapie einer Erektionsstörung ist die Kenntnis der anatomischen Strukturen und physiologischen Abläufe, die für das Entstehen, Aufrechterhalten und den Rückgang der Erektion von Bedeutung sind. Dabei ist es historisch interessant, daß bis Ende der 7oer Jahre dieses Jahrhunderts Erektionsstörungen als überwiegend psychogen klassifiziert wurden, obwohl bereits Eckhard 1863 und später v. Ebner erste physiologische Untersu¬chungen des Erektionsablaufs duchgeführt hatten [3, 4]. Diese Erkenntnisse gerieten leider lange Jahrzehnte in Vergessenheit. Erst die Möglichkeit der Induktion einer artifiziellen Erektion durch Injektion vasoaktiver Substanzen sollte das anatomische und physiologische Grundverständnis des Erektionsablaufs ändern und die bis dato geltende Lehrmeinung einer arteriellen Shunt therorie in Frage stellen [2].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Literatur

  1. Comarr AE (1970) Sexual function among patients with spinal cord injury. Urol Int 25:134–168

    PubMed  CAS  Google Scholar 

  2. Conti G (1952) L’érection du penis humain et ses bases morphologico-vasculaires. Acta Anat 14:217

    PubMed  CAS  Google Scholar 

  3. Ebner V von (1900) Über klappenartige Vorrichtungen in den Arterien der Schwellkörper. Anat Anz 18:79

    Google Scholar 

  4. Eckhard C (1863) Untersuchungen über die Erektion beim Hunde. Beitr Anat Physiol 3:123

    Google Scholar 

  5. Fournier GR Jr, Juenemann KP, Lue TF, Tanagho EA (1987) Mechanisms of venous occlusion during canine penile erection:an anatomic demonstration. J Urol 137:16–167

    PubMed  Google Scholar 

  6. Jünemann KP (1988) Physiologie der penilen Erektion. In:Bähren W, Altwein JE (Hrsg) Impotenz. Diagnostik and Therapie in Klinik and Praxis. Thieme, Stuttgart

    Google Scholar 

  7. Jünemann KP (1992) Erektionsstörungen. In:Alken P, Walz K (Hrsg) Urologie. VCH, Weinheim, Kap. 12

    Google Scholar 

  8. Jünemann KP, Lue TF, Abozeid M, Hellstrom WJ, Tanagho EA (1986) Blood gas analysis in drug-induced penile erection. Urol Int 41:207–211

    Google Scholar 

  9. Jünemann KP, Lue TF, Fournier GR Jr, Tanagho EA (1986) Hemodynamics of papaverine and phentolamine-induced penile erection. J Urol 136:158–161

    Google Scholar 

  10. Jünemann KP, Luo JA, Lue TF, Tanagho EA (1986) Further evidence of venous outflow restriction during erection. Br J Urol 58:320–324

    Google Scholar 

  11. Jünemann KP, Persson-Jünemann C, Lue TF, Tanagho EA, Alken P (1989) Neurophysiological aspects of penile erection. Brit J Urol 64:84–92

    PubMed  Google Scholar 

  12. Jünemann KP, Persson-Jünemann C, Tanagho EA, Alken P (1989) Neurophysiology of penile erection. Urol Res 17:21–217

    PubMed  Google Scholar 

  13. Lavoisier P, Courtois F, Barres D, Blanchard M (1986) Correlation between intracavernous pressure and contraction of the ischiocavernosus muscle in man. J Urol 136:936–939

    PubMed  CAS  Google Scholar 

  14. Lue TF, Takamura T, Schmidt RA, Palubinskas AJ, Tanagho EA (1983) Hemodynamics of erection in the monkey. J Urol 130:1237–1241

    PubMed  CAS  Google Scholar 

  15. Lue TF, Zeineh SJ, Schmidt RA, Tanagho EA (1983) Physiology of penile erection. World J Urol 1:194

    Google Scholar 

  16. Lue TF, Takamura T, Umraiya M, Schmidt RA, Tanagho EA (1984) Hemodynamics of canine corpora cavernosa during erection. Urology 24:347–352

    PubMed  CAS  Google Scholar 

Literatur

  1. Montorsi F, Salonia A, Scifo P, Anchisi D, Rigiroli P, Zanoni M, Ferrucio F (2000) Human cerebral activation by apomorphine after neutral and erotic visual stimulation. IJIR [Suppl]:88

    Google Scholar 

  2. Banner LL, Arnow B, Atas S, Desmond J, Glover G, Polan M, Lue TF (2001) Brain activation during sexual arousal with functional MRI. J Urol 165:222

    Google Scholar 

  3. Chuang AT, Steers WD (1999) Neurophysiology of penile erection. Textbook of erectile dysfunction. ISIS

    Google Scholar 

  4. Rampin O, Giuliano F (2001) Brain control of penile erection. W J Urol 19:1–8

    CAS  Google Scholar 

  5. Rampin O, Bernabe J, Guilano F (1997) Spinal control of penile erection. W J Urol 15:2–13

    CAS  Google Scholar 

  6. Melis MR, Argiolas A (1995) Dopamine and sexual behavior. Neurosci Behav Rev 19:19

    CAS  Google Scholar 

  7. Chen KK, Chan JY, Chang LS (1999) Dopaminergic neurotransmission at the paraventricular nucleus of hypothalamus in the central regulation of penile erection. J Urol 162:237

    PubMed  CAS  Google Scholar 

  8. Shabsigh R (1997) The effects of testosterone on the cavernous tissue and erectile function. W J Urol 15:21–26

    CAS  Google Scholar 

  9. Park K, Seo JJ, Kang HK, Ryu SB, Kim HJ, Jeong GW (2001) A new potential for blood oxygenation level dependent functional MRI. Int J Impotence Res 13:73

    CAS  Google Scholar 

  10. Marson L (1999) Central nervous system control. Textbook of erectile dysfunction. ISIS

    Google Scholar 

Literatur

  1. Sonnenburg W, Beavo J (1994) Cyclic GMP and regulation of cyclic nucleotide hydrolysis. In:Murad F (ed) advances in pharmacology:cyclic GMP:synthesis, metabolism, and function. Vol 26. Academic Press, San Diego, pp 87–114

    Google Scholar 

  2. Barber R, Goka T, Butcher R (1992) Cyclic AMP turnover in intact tissue:role of cyclic nucleotide phosphodiesterases. In:Strada S, Hidaka H (eds) Advances in second messenger and phosphoprotein research. Vol 25. Raven Press, New York, pp 1–11

    Google Scholar 

  3. Stief C, Ückert S, Becker A, Truss M, Jonas U (1998) The effect of the specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo. J Urol 159:1390–1393

    Google Scholar 

  4. Gingell C, Buvat J, Jardin A et al. (1999) Sildenafil citrate (VIAGRA), an oral treatment for erectile function:1-year, open-label, extension studies. Multicentre Study Group. Int J Clin Pract 102:30–31

    Google Scholar 

  5. Padma-Nathan H, McMurray J, Saoud J, Ferguson K, Dullman W, Whitaker S, Rosen R (2000) On-demand treatment of erectile dysfunction with IC 351. Eur Urol 37:81

    Google Scholar 

  6. Klotz T, Sachse R, Heidrich A, Jockenhovel F, Rohde G, Wensing G, Horstmann R, Engelmann R (2001) Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients:a RigiScan and pharmacokinetic study. World J Urol 19:32–39

    PubMed  CAS  Google Scholar 

  7. Beavo J, Hansen R, Harrison S, Hurwitz R, Martins T, Mumby M (1982) Identification and properties of cyclic nucleotide phosphodiesterases. Mol Cell Endocrinol 28:387–410

    PubMed  CAS  Google Scholar 

  8. Charbonneau H (199o) Structure-function relationships among cyclic nucleotide phosphodiesterases. In:Beavo J, Housley M (eds) structure, regulation, and drug action. Wiley & Sons, New York

    Google Scholar 

  9. Loughney K, Ferguson K (1996) Identification and quantification of PDE isoenzymes and subtypes by molecular biological methods. In:Schudt C, Dent G, Rabe K (eds) Phosphodiesterase inhibitors. Academic Press, New York, pp 1–19

    Google Scholar 

  10. Beavo J, Conti M, Heaslip R (1994) Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol 46:399–405

    PubMed  CAS  Google Scholar 

  11. Hall I (1993) Isoenzyme selective phosphodiesterase inhibitors:potential clinical uses. Br J Clin Pharmacol 35:1–7

    PubMed  CAS  Google Scholar 

  12. Stoclet J, Keravis T, Komas N, Lugnier C:Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiovascular diseases. Exp. Opin. Invest. Drugs 1995 4:1081–1100.

    CAS  Google Scholar 

  13. Burns F, Zhao A, Beavo JA (1996) Cyclic nucleotide phosphodies terases:gene complexity, regulation by phosphorylation, and physiological implications. Adv Pharmacol 36:29–48

    PubMed  CAS  Google Scholar 

  14. Corbin J, Francis S (1999) Cyclic GMP phosphodiesterase-5:target of sildenafil. J Biol Chem 274:13729–13732

    PubMed  CAS  Google Scholar 

  15. Juilfs D, Soderling S, Burns F, Beavo J (1999) Cyclic GMP as substrate and regulator of cyclic nucleotide phosphodiesterases (PDEs). Rev Physiol Biochem Pharmacol 135:67–104

    PubMed  CAS  Google Scholar 

  16. Soderling S, Bayuga S, Beavo J (1999) Isolation and characterization of a dual-substrate phosphodiesterase gene family. Proc Natl Acad Sci U S A 96:7071–7076

    PubMed  CAS  Google Scholar 

  17. Fawcett L, Baxendale R, Stacey P et al. (2000) Molecular cloning and characterization of a distinct human phosphodiesterase gene family PDE11A. Proc Natl Acad Sci. U S A 97:3702–3707

    CAS  Google Scholar 

  18. Shakur Y, Holst L, Landstrom T, Movsesian M, Degerman E, Manganiello V (2000) Regulation and function of the cyclic nucleotide phosphodies terase (PDE3) gene family. Prog Nucleic Acid Res Mol Biol 66:241–277

    CAS  Google Scholar 

  19. Beavo J (1995) Cyclic nucleotide phosphodiesterases:functional implications of multiple isoforms. Physiol Rev 75:725–748

    PubMed  CAS  Google Scholar 

  20. Manganiello V, Murata T, Taira M, Belfrage P, Degerman E (1995) Diversity in cyclic nucleotide phosphodiesterase isoenzyme families. Arch Biochem Biophys 322:1–13

    PubMed  CAS  Google Scholar 

  21. Houslay M, Milligan G (1997) Tailoring cAMP-signalling responses through isoform multiplicity. Trends Biochem Sci 22:217–224

    PubMed  CAS  Google Scholar 

  22. Beavo J, Reifsnyder D (1990) Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmac Sci 11:150–155

    CAS  Google Scholar 

  23. Nicholson C, Challiss R, Shahid M (1991) Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol Sci 12:19–27

    PubMed  CAS  Google Scholar 

  24. Conti M, Jin S (1999) The molecular biology of cyclic nucleotide phosphodiesterases. Prog Nucleic Acid Res Mol Biol 63:1–63

    PubMed  CAS  Google Scholar 

  25. Doerner D, Alger B (1988) Cyclic GMP depresses hippocampal Ca2+ current through a mechanism independent of cGMP-dependent protein kinase. Neuron 1:69–699

    PubMed  CAS  Google Scholar 

  26. MacFarland R, Zelus B, Beavo J (1991) High concentrations of a cGMP-stimulated phosphodiesterase mediate ANP-induced decreases in cAMP and steroidogenesis in adrenal glomerulosa cells. J Biol Chem 266:136–142

    PubMed  CAS  Google Scholar 

  27. Dickinson N, Jang E, Haslam R (1997) Activation of cGMP-stimulated phosphodiesterase by nitroprusside limits cAMP accumulation in human platelets:effects on platelet aggregation. Biochem J 323:371–377

    PubMed  CAS  Google Scholar 

  28. Wang J, Sharma R, Mooibroek M (1990) Calmodulin-stimulated cyclic nucleotide phosphodiesterases. In:Beavo J, Houslay M (eds) Cyclic nucleotide phosphodiesterases:structure, regulation and drug action. Vol 2. Wiley, Chichester, pp 19–60

    Google Scholar 

  29. Schwede F, Maronde E, Genieser H, Jastorff B (2000) Cyclic nucleotide analogs as biochemical tools and prospective drugs. Pharmacol Ther 87:199–226

    PubMed  CAS  Google Scholar 

  30. Robison G, Butcher R, Sutherland E (1971) Formation and metabolism of cyclic AMP In:Cyclic AMP Academic Press, New York, pp 7–90

    Google Scholar 

  31. Rassier M, McIntyre S, Yamaki M, Takeda S, Lin J, DOUSA T (1992) Isoenzymes of cyclic-3’,5’-nucleotide phosphodiesterases in renal epithelial LLCPK, cells. Kidney Int 41:88–99

    PubMed  CAS  Google Scholar 

  32. Thompson W (1991) Cyclic nucleotide phosphodiesterases:pharmacology, biochemistry and function. Pharmacol Ther 51:1–33

    PubMed  CAS  Google Scholar 

  33. Degerman E, Belfrage P, Manganiello V (1997) Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). J Biol Chem 272:682–6826

    PubMed  CAS  Google Scholar 

  34. Komas N, Movsesian M, Kedev S, Degerman E, Belfrage P, Manganiello V (1996) cGMP inhibited phosphodiesterases (PDE3). In:Schudt C, Dent G, Rabe K (eds) Phosphodiesterase inhibitors. Academic Press, New York, pp 89–109

    Google Scholar 

  35. Souness J, Rao S (1997) Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodiesterases. Cell Signal 9:227–236

    PubMed  CAS  Google Scholar 

  36. Teixeira M, Gristwood R, Cooper N, Hellewell P (1997) Phosphodiesterase (PDE) 4 inhibitors:Anti-inflammatory drugs of the future? Trends Pharmacol Sci 18:164–171

    PubMed  CAS  Google Scholar 

  37. Ahn H, Crim W, Pitis B, Sybertz E (1992) Calcium- calmodulin-stimulated and cyclic GMP-specific phosphodiesterases:Tissue distribution, drug sensitivity, and regulation of cyclic GMP levels. Adv Second Messenger Phosphoprotein Res 25:271–288

    PubMed  CAS  Google Scholar 

  38. Silver P (1996) Inhibition of phosphodiesterase isoenzymes and cell function by selective PDE5 inhibitors. In:Schudt C, Dent G, Rabe K (eds) Phosphodiesterase inhibitors. Academic Press, New York, pp 127–134

    Google Scholar 

  39. Moreland R, Goldstein I, Kim N, Traish A (1999) Sildenafil citrate, a selective phosphodiesterase typr 5 inhibitor:research and clinical implications in erectile dysfunction. Trends Endocrinol Metab 10:97–104

    PubMed  CAS  Google Scholar 

  40. Dousa T (1999) Cyclic-3’,5’-nucleotide phosphodiesterase isoenzymes in cell biology and pathophysiology of the kidney. Kidney Int 55:29–62

    PubMed  CAS  Google Scholar 

  41. Gillespie P (1990) Phosphodiesterases in visual transduction by rods and cones. In:Beavo J, Housley M (eds) Cyclic nucleotide phosphodiesterases:structure, functio, regulation and drug action. Wiley, Chichester, pp 16–184

    Google Scholar 

  42. Taher A, Meyer M, Stief C, Jonas U, Forssmann W (1997) Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle. World J Urol 15:32–35

    PubMed  CAS  Google Scholar 

  43. Boolell M, Allen M, Ballard S et al. (1996) Sildenafil:an orally active type 5 cyclic GMP specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 8:47–52

    PubMed  CAS  Google Scholar 

  44. Ballard S, Gingell C, Tang K, Turner L, Price M, Naylor A (1998) Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 159:2164–2171

    PubMed  CAS  Google Scholar 

  45. Stief C, Ückert S, Becker A, Harringer W, Truss M, Forssmann W, Jonas U (2000) Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue. Urology 55:146–150

    PubMed  CAS  Google Scholar 

  46. Wallis R, Corbin J, Francis S, Ellis P (1999) Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro. Am J Cardio183:3C–12C

    Google Scholar 

  47. Kuthe A, Wiedenroth A, Magert H, Ockert S, Forssmann W, Stief C, Jonas U (2001) Expression of different phosphodiesterase genes in human cavernous smooth muscle. J Urol 165:280–283

    PubMed  CAS  Google Scholar 

  48. Strachan T, Read A (1996) Molekulare Humangenetik. Die Expression der menschlichen Gene. Spektrum Akademischer Verlag, Heidelberg

    Google Scholar 

  49. Pelligrino D, Wang Q (1998) Cyclic nucleotide crosstalk and the regulation of cerebral vasodilation. Prog Neurobio156:1–18

    Google Scholar 

  50. Bourguignon J, Desaubry P, Wermuth C, Lugnier C (1997) 9-Benzyladenines:Potent and selective cAMP phosphodiesterase inhibitors. J Med Chem 40:1768–1770

    Google Scholar 

  51. Kuthe A, Magert H, Ockert S, Forssmann W, Stief C, Jonas U (2000) Gen expression of the phosphodiesterase 3 A and 5 A in human corpus cavernosum. Eur Urol 38:108–114

    PubMed  CAS  Google Scholar 

  52. Goldstein I, Lue T, Padman-Nathan H, Rosen R, Steers W, Wicke P (1998) Oral Sildenafil in the treatment of erectile dysfunction. New Engl J Med 338:1397–1403

    PubMed  CAS  Google Scholar 

  53. Langtry H, Markham A (1999) Sildenafil a review of its use in erectile dysfunction. Drugs 57:967–989

    PubMed  CAS  Google Scholar 

  54. Rulten S, Dapling J, Lanfa S, Steel J, Turay P, Paulson R (1998) Isolation of human phosphodiesterase 5 cDNA and in situ analysis of its expression in human corpus cavernosum. J Urol 159:92

    Google Scholar 

  55. Kuthe A, Eckel H, Stief C, Ockert S, Forssmann W, Jonas U, Magert H (1999) Molecular biological characterization of phosphodiesterase 3 A from human corpus cavernosum. Chem Biol Interact 119–120:59–598

    Google Scholar 

  56. Lin C, Lau A, Tu R, Lue T (2000) Expression of three isoforms of cGMP-binding cGMP¬specific phosphodiesterase (PDE5) in human penile cavernosum. Biochem Biophys Res Commun 268:628–635

    PubMed  CAS  Google Scholar 

  57. Kim N, Huang Y, Moreland R, Kwak S (2000) Cross-regulation of intracellular cGMP and cAMP in cultured human corpus cavernosum smooth muscle cells. Mol Cell Biol Res Commun 4:10–14

    PubMed  CAS  Google Scholar 

Literatur

  1. Aboseif SR, Wetterauer U, Breza J et al. (1990) The effect of venous incompetence and arterial insufficiency on erectile function:an animal model. J Urol 144:790–793

    PubMed  CAS  Google Scholar 

  2. Angermann I (198o) Psychodynamik and Psychotherapie der gestorten Sexualitat. In:Eicher W (Hrsg) Sexualmedizin in der Praxis. Fischer, Stuttgart

    Google Scholar 

  3. Bähren W, Gall H, Scherb W, Holzki G, Sparwasser C (1991) Pharmacoarteriography in chronic erectile dysfunction. In:Jonas U et al. (eds) Erectile dysfunction. Springer, Berlin Heidelberg New York Tokyo, pp 34–43

    Google Scholar 

  4. Bartsch G, Scheiber K (1983) Endocrinologic aspects of disturbed potency. World J Urol 1:197–202

    Google Scholar 

  5. Becker N (1975) Psychoanalytische Ansatze bei der Therapie sexueller Funktionsstorungen. In:Sigusch V (Hrsg) Therapie sexueller Störungen. Thieme, Stuttgart

    Google Scholar 

  6. Brindley GS (1983) Cavernousal alpha-blockade:a new technique for investigating and treating erectile impotence. Brit J Psychiat 143:332

    PubMed  CAS  Google Scholar 

  7. DePalma RG, Levine SB, Feldmann S (1978) Preservation of erectile function after aortoiliac reconstruction. Arch Surg 113:958

    PubMed  CAS  Google Scholar 

  8. Ellenberg M (1971) Impotence in diabetes:the neurologic factor. Ann Intern Med 75:213

    PubMed  CAS  Google Scholar 

  9. Jevtich MJ, Kass M, Khawand N (1985) Changes in the corpora cavernosa of impotent diabetics. Comparing histological with clinical findings. J Urol (Paris) 91:281

    CAS  Google Scholar 

  10. Jünemann KP, Lue TF,Melchior H (1987) Die Physiologie der penilen Erektion. II. Neurophysiologie der penilen Erektion. Urologe [A] 26:283–288

    Google Scholar 

  11. Jünemann KP, Lue TF, Melchior H (1987) Die Physiologie der penilen Erektion. II. Neurophysiologie der penilen Erektion. Urologe [A] 26:28–288

    Google Scholar 

  12. Kockott G (1981) Sexuelle Funktionsstörungen des Mannes. Enke, Stuttgart (Beitr Sexualforsch 58 )

    Google Scholar 

  13. Leriche R, Morel A (1948) The syndrome of thrombotic obliteration of the aortic bifurcation. Ann Surg 127:193

    Google Scholar 

  14. Lue TF, Zeineh SJ, Schmidt A, Tanagho EA (1984) Neuroanatomy of penile erection:its relevance to iatrogenic impotence. J Uro1131:273

    Google Scholar 

  15. Matussek P (1971) Funktionelle Sexualstorungen. In:Giese H (Hrsg) Die Sexualität des Menschen. Enke, Stuttgart

    Google Scholar 

  16. May AG, DeWeese JA, Rob CG (1969) Changes in sexual function following operation on the abdominal aorta. Surgery 65:41

    PubMed  CAS  Google Scholar 

  17. Metz P, Herning M (1984) Impotence and aorto-iliac disease with special reference to the pelvic steal syndrome. Int Angiol 3:259

    Google Scholar 

  18. Nath RL, Menzoian JO, Kaplan KH, McMillian TN, Siroky MB, Krane RJ (1981) The multidisciplinary approach to vasculogenic impotence. Surgery 89:124

    PubMed  CAS  Google Scholar 

  19. Nickel CJ, Morales A, Condra M, Fenemore J, Surridge DH (1984) Endocrine dysfunction in impotence:incidence, significance and cost-effective screening. J Urol 132:40–43

    PubMed  CAS  Google Scholar 

  20. Porst H, Ahlen HV, Leipner N, Koster O (1986) Dynamische Kavernosographie. Fortschr Röntgenstr 145:80

    CAS  Google Scholar 

  21. Rotter W, Schürmann R (1950) Die Blutgefäße des menschlichen Penis. Arch Path Anat 318:352

    CAS  Google Scholar 

  22. Staubesand J, Wetterauer U, Kuvelis F (1991) Ultrastuctural findings in patients with erectile dysfunction. In:Jonas U et al. (eds) Erectile dysfunction. Springer, Berlin Heidelberg New York Tokyo, pp 34–43

    Google Scholar 

  23. Stief CG, Thon WF, Gall H, Scherb W, Schnell D, Altwein JE, Bähren W (1987) Die venöse Insuffizienz der Corpora cavernosa als (Mit-)Ursache der erektilen Dysfunktion. Urologe [A] 26:83

    CAS  Google Scholar 

  24. Virag R (1982) Intracavernous injection injection of papaverine for erectile failure. Lancet II:938

    Google Scholar 

  25. Virag R, Frydman D, Legman M, Floresco J, Bouilly P (1984) Hemodynamic evaluation of arterial and venous lesions as a cause of impotence. Int Angiol 3:241

    Google Scholar 

  26. Wagner G (1984) Vascular mechanism involved in human erection. Int Angiol 3:221

    Google Scholar 

  27. Walsh PC, Donker PJ (1982) Impotence following radical prostatectomy:insight into etiology and prevention. J Urol 128:492

    PubMed  CAS  Google Scholar 

  28. Wetterauer U, Stief CG, Kuvelis F, Staubesand J, Sommerkamp H (1989) Ultrastukturelle Veränderungen des cavernösen Gewebes and der Tunica albuginea bei erektiler Impotenz. Verh Ber Dt Ges Urol 27:356–358

    Google Scholar 

Literatur

  1. Anderson RA, Bancroft J, Wu FCW (1992) The effects of exogenous testosterone on sexuality and mood of normal men. J Clin Endocrinol Metab 75:150–1507

    PubMed  CAS  Google Scholar 

  2. Behre HM, Nieschlag E (1992) Testosterone buciclate (20 Aet-1) in hypogonadal men:pharmacokinetics and pharmacodynamics of the new long-acting androgen ester. J Clin Endocrinol Metab 75:1204–1210

    PubMed  CAS  Google Scholar 

  3. Behre HM, Böckers A, Schlingheider A, Nieschlag E (1994) Sustained suppression of serum LH, FSH, and testosterone and increase of high-density lipoprotein cholesterol by daily injections of the GnRH antagonist cetrorelix over 8 days in normal men. Clin Endocrinol 40:241–248

    CAS  Google Scholar 

  4. Behre HM, Yeung CH, Nieschlag E (1996) Diagnostik der Infertilität and des Hypogonadismus. In:Nieschlag E, Behre HM (Hrsg) Andrologie — Grundlagen and Klinik der reproduktiven Gesundheit des Mannes. Springer, Berlin Heidelberg New York, S 89–117

    Google Scholar 

  5. Buena F, Peterson MA, Swerdloff RS et al. (1993) Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal range. J Clin Endocrinol Metab 59:1118–1123

    CAS  Google Scholar 

  6. Christiansen K (1998) Behavioural correlates of testosterone. In:Nieschlag E, Behre HM (eds) Testosterone - action, deficiency, substitution, 2nd edn. Springer, Berlin Heidelberg New York Tokyo, pp 107–142

    Google Scholar 

  7. Davidson JM, Camargo CA, Smith ER (1979) Effects of androgen on sexual behavior in hypogonadal men. J Clin Endocrinol Metab 48:955–958

    PubMed  CAS  Google Scholar 

  8. Deutsche Gesellschaft für Endokrinologie (Hrsg) (1993) Rationelle Diagnostik in der Endokrinologie einschließlich Diabetologie and Stoffwechsel. Thieme, Stuttgart

    Google Scholar 

  9. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994) Impotence and its medical and psychosocial correlates:results of the Massachusetts male aging study. J Uro1151:54–61

    Google Scholar 

  10. Gooren LJ (1987) Androgen levels and sex functions in testosterone-treated hypogonadal men. Arch Sex Behav 16:46–473

    PubMed  CAS  Google Scholar 

  11. Hubert W (199o) Psychotropic effects of testosterone. In:Nieschlag E, Behre HM (eds) Testosterone - action, deficiency, substitution. Springer, Berlin Heidelberg New York Tokyo, pp 51–71

    Google Scholar 

  12. Korenman SG, Morley JE, Mooradian AD et al. (1990) Secondary hypogonadism in older men:its relation to impotence. J Clin Endocrinol Metab 71:96–969

    PubMed  CAS  Google Scholar 

  13. Martini L, Melcangi C, Celotti F (1992) Androgens and the brain:role of testosterone metabolism. In:Nieschlag E, Habenicht OF (eds) Spermatogenesis - fertilization - contraception. Molecular, cellular and endocrine events in male reproduction. Springer, Berlin Heidelberg New York Tokyo, pp 12–142

    Google Scholar 

  14. Mooradian AD, Morley JE, Korenman SG (1987) Biological actions of androgens. Endocr Rev 8:1–28

    PubMed  CAS  Google Scholar 

  15. O’Carroll R, Shapiro C, Bancroft J (1985) Androgens, behaviour and nocturnal erection in hypogonadal men:the effects of varying the replacement dose. Clin Endocrinol 23:527–538

    Google Scholar 

  16. Tschöp M, Behre HM, Nieschlag E, Dressendörfer RA, Strasburger CJ (1998) A timeresolved fluorescence immunoassay for the measurement of testosterone in saliva:monitoring of testosterone replacement therapy with testosterone buciclate. J Clin Chem Clin Biochem 36:22–230

    Google Scholar 

  17. Tsitouras PD, Martin CE, Harman AM (1982) Relationship of serum testosterone to sexual activity in healthy elderly men. J Geronto137:288–293

    Google Scholar 

  18. Vermeulen A, Verdonck G (1992) Representativeness of a single point plasma testosterone level for the long term hormonal milieu. J Clin Endocrinol Metab 74:939–942

    PubMed  CAS  Google Scholar 

Literatur

  1. Althof SE (1989) Psychogenic impotence:treatment of men and couples. In:Leiblum SR, Rosen RC (eds) Principles and practice of sex therapy. update for the 1990s. Guilford, New York

    Google Scholar 

  2. Bancroft J (1993) But what is psychogenic erectile dysfunction? Int J Impot Res 5:205–206

    Google Scholar 

  3. Bancroft J (1994) What is psychogenic erectile dysfunction? Paper presented at the 2nd Conference of the European Federation of Sexology Copenhagen

    Google Scholar 

  4. Bancroft J, Janssen E (20o1) The dual control model of male sexual response:a theoretical approach. Neurosci Biobehav Rev (in press)

    Google Scholar 

  5. Barlow DH (1986) Causes of sexual dysfunctions:the role of anxiety and cognitive interference. J Consult Clin Psycho154:140–148

    Google Scholar 

  6. Beier KM, Bosinski HAG, Hartmann U, Loewit K (2001) Sexualmedizin. Urban & Fischer, München

    Google Scholar 

  7. Fenichel O (1980) Psychoanalytische Neurosenlehre, Bd I. Olten, Freiburg

    Google Scholar 

  8. Freud S (1910) Über die allgemeinste Erniedrigung des Liebeslebens. In:Freud S ( 1964 ) Gesammelte Werke VIII. S. Fischer, Frankfurt

    Google Scholar 

  9. Hartmann U (1994) Diagnostik and Therapie der erektilen Dysfunktion. Theoretische Grundlagen and Praxisempfehlungen aus einer multidisziplinären Spezialsprechstunde. Lang, Frankfurt/M

    Google Scholar 

  10. Hartmann U (1995) Die kombinierte psycho-somatische Behandlung erektiler Dysfunktionen. Psycho 21:651–657

    Google Scholar 

  11. Hartmann U (1997) Psychological subtypes of erectile dysfunctions:results from statistical analyses and clinical practice. World J Urol 15:56–64

    PubMed  CAS  Google Scholar 

  12. Janssen E, Everaerd W (1993) Determinants of male sexual arousal. In:Bancroft J (ed) Annual review of sex research Vol 4. SSSS, Mount Vernon

    Google Scholar 

  13. Janssen E, Bancroft J (1996) Dual control of sexual response:the relevance of central inhibition. Paper presented at the 22nd Meeting of the International Academy of Sex Research Rotterdam

    Google Scholar 

  14. Kaplan HS (1974) The new sex therapy. Brunner/Mazel, New York

    Google Scholar 

  15. Kaplan HS (1981) Hemmungen der Lust. Enke, Stuttgart

    Google Scholar 

  16. Langer D, Hartmann U (1992) Psychosomatik der Impotenz. Enke, Stuttgart

    Google Scholar 

  17. Levine SB (1992) Intrapsychic and interpersonal aspects of impotence:psychogenic erectile dysfunction. In:Rosen RC, Leiblum SR (eds) Erectile dirorders. Assessment and treatment. Guilford, New York

    Google Scholar 

  18. Levine SB, Althof SE (1991) The pathogenesis of psychogenic erectile dysfunction. J Sex Educat Ther 17:251

    Google Scholar 

  19. Lue TF (1993) Erectile dysfunction:Problems and challenges. J Urol 149:1256–1257

    PubMed  CAS  Google Scholar 

  20. Masters WH, Johnson VE (1970) Human sexual inadequacy. Little Brown & Company, Boston (Dtsch:Impotenz and Anorgasmie. Goverts Kröger Stahlberg, Frankfurt 1973 )

    Google Scholar 

  21. National Institutes of Health (1992) Consensus Development Conference Statement on Impotence. Bethesda National Institutes of Health

    Google Scholar 

Literatur

  1. Aboseif S, Riemer RK, Stacl W (1993) Quantification of PGE1 receptors in cavernous tissue of men, monkeys and dogs. Urol Int 50:48–52

    Google Scholar 

  2. Amiel SA (1993) Diabetic control and complications. BMJ 307 /6909:881–882

    PubMed  CAS  Google Scholar 

  3. Andersson KE, Stief CG (1997) Neurotransmission and the contraction and relaxation of penile erectile tissues. World J Urol 15:14–20

    PubMed  CAS  Google Scholar 

  4. Atkinson MA, MacLaren NK (1994) The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331 /21:1428–1436

    PubMed  CAS  Google Scholar 

  5. Bancroft J, Gutierrez P (1996) Erectile dysfunction in men with and without diabetes mellitus a comparative study. Diab Med 13:84–89

    CAS  Google Scholar 

  6. Bell CRW, Sullivan ME, Dashwood MR, Thompson CS Muddle JR, Morgan RJ (1995) The density and distribution of endothelin 1 and endothelin receptor subtypes in normal and diabetic rat corpus cavernosum. Br J Urol 76:20–207

    PubMed  CAS  Google Scholar 

  7. Bemelmans BL, Meuleman EJ, Doesburg WH, Notermans SL, Debruyne FM (1994) Erectile dysfunction in diabetic men the neurological factor revisited. J Urol 151 /4:884–889

    PubMed  CAS  Google Scholar 

  8. Bishop JR, Moul JW, Sihelnik SA, Peppas DS, Gormley TS, McLeod DG (1992) Use of glycosylated hemoglobin to identify diabetics at high risk for penile periprostehtic infections. J Urol 147:386–388

    PubMed  CAS  Google Scholar 

  9. Blanco R, Saenz de Tejada IS, Goldstein I, Frane RJ, Wotiz HH, Cohen RA (1990) Dysfunctional penile cholinergic nerves in diabetic impotent men. J Urol 144:278–280

    PubMed  CAS  Google Scholar 

  10. Bodansky HJ (1994) Treatment of male erectile dysfunction using the active vacuum assist device. Diabet Med 11 /4:410–412

    PubMed  CAS  Google Scholar 

  11. Braun M, Klotz T, Reifenrath B, Mathers M, Wassmer G, Schoenberger A, Engelmann U (2000) Die Prävalenz von männlichen Erektionsstörungen in Deutschland heute und in der Zukunft. Akt Urol 31:302–307 )

    Google Scholar 

  12. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U (2000) Epidemiology of eretile dysfunction Results of the Cologne Male Survey. Int J Impot Res 12:305–311

    PubMed  CAS  Google Scholar 

  13. Burchardt T, Burchardt M, Karden J et al. (2000) Reduction of endothelial and smooth muscle density in the corpora cavernosa of the streptozotozin induced diabetic rat. J Urol 164:1807–1811

    PubMed  CAS  Google Scholar 

  14. Burnett AL, Lowenstein CJ, Bredt D, Chang TSK, Snyder SH (1992) Nitric oxide a physio¬logic mediator of penile erection. Science 257:401–403

    PubMed  CAS  Google Scholar 

  15. Buvat J, Lemaire A, Buvat-Herbaut M, Guien JD, Bailleul JP, Fossati P (1985) Comparative investigations in 26 impotent and 26 nonimpotent diabetic patients. J Urol 133:34–38

    PubMed  CAS  Google Scholar 

  16. Cameron NE, Cotter MA, Archibald V, Dines KC, Maxfield EK (1994) Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non- diabetic and streptozotocin-diabetic rats. Diabetologia 37:449–459

    PubMed  CAS  Google Scholar 

  17. Cartledge JJ, Eardley I, Morrison JFB (2000) Impairment of corpus cavernosal smooth muscle relaxation by glycosylated human haemoglobin. BJU Int 85:735–741

    PubMed  CAS  Google Scholar 

  18. Cartledge JJ, Eardley I, Morrison JFB (2001) Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes. BJU Int 87 402–407

    PubMed  CAS  Google Scholar 

  19. Centers for Disease Control and Prevention Diabets Surveillance, 1997. US Department of Health and Human Services, Atlanta, GA

    Google Scholar 

  20. Ceriello A, Quatraro A, Caretta F, Varano R, Giugliano D (1990) Evidence for a possible role of oxygen free radicals in the abnormal functional arterial vasomotion in insulin-dependent diabetes. Diabetes Metab 16:318–322

    CAS  Google Scholar 

  21. Christ GJ (2000) Gap junctions and ion channels relevance to erectile dysfunction. Int J Impot Res 12 [Suppl 4]:15–25

    Google Scholar 

  22. Cohen RA (1993) Dysfunction of vascular endothelium in diabetes mellitus. Circulation 87 [Suppl V]:67–76

    Google Scholar 

  23. Colakoglu Z, Kutluay E, Ertekin C, Altay B, Killi R, Alkis A (1999) Autonomic nerve involvement and venous leakage in diabetic men with impotence. BJU Int 83:45–456

    PubMed  CAS  Google Scholar 

  24. DePalma RG (1997) Vascular surgery for impotence a review. Int J Impot Res 9:61–67

    PubMed  CAS  Google Scholar 

  25. Diabetes Epidemiology Research International Mortality Study Group (1991) Major cross-country differences in risk of dying for people with IDDM. Diabetes Care 14:49–54

    Google Scholar 

  26. Djamilian MH, Stein J, Fröhlich T, Stief CG, Thon WF (1997) Intrakavernöse Phenylephrininjektion bei pharmakologisch induzierter prolongierter Erektion. Urologe B 37:45–47

    Google Scholar 

  27. Dunsmuir WD, Holmes SA (1996) The aetiology and mangement of erectile, ejaculatory, and fertility problems in men with diabetes mellitus. Diabet Med 13:700–708

    PubMed  CAS  Google Scholar 

  28. Earle CM, Seah M, Coulden SE, Stuckey BGA, Keogh EJ (1996) The use of the vacuum erection device in the mangement of erectile dysfunction. Int J Impot Res 8 /4:237–240

    PubMed  CAS  Google Scholar 

  29. Ebbehoj J, Wagner G (1979) Insufficient penile erection due to abnormal drainage of cavernous bodies. Urology 13:507–510

    PubMed  CAS  Google Scholar 

  30. El-Bahrawy M, el-Baz MA, Emam A, el-Magd MA (1995) Noninvasive vacuum constriction device in the mangement of erectile dysfunction. Int J Urol 27 /3:331–333

    CAS  Google Scholar 

  31. El-Sakka AI, Lin CS, Chui RM, Dahiya R, Lue TF (1999) Effects of diabetes on nitric oxide synthase and growth factor genes and protein expression in an animal model. Int J Impot Res 11:12–132

    PubMed  CAS  Google Scholar 

  32. Ellenberg M (1971) Impotence in diabetes the neurologic factor. Ann Intern Med 75:21–219

    PubMed  CAS  Google Scholar 

  33. Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropathy. Br Med J 285:916–918

    CAS  Google Scholar 

  34. Fairburn CG, McCulloch DK, Wu FC (1982) The effects of diabetes on male sexual function. Clin Endocrinol Metab 11:749–767

    PubMed  CAS  Google Scholar 

  35. Fedele D, Coscelli C, Santeusanio F et al. (1998) Erettile Nei Diabetici Erectile dysfunction in diabetic subjects in Italy. Diabets Care 21 /11:197–1977

    CAS  Google Scholar 

  36. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994) Impotence and its medical and psychosocial correlates Results of the Massachusetts Male Aging Study. J Urol 151:54–61

    PubMed  CAS  Google Scholar 

  37. Fishel B, Chen J, Alon M, Zhukovsky G, Matzkin H (2000) The value of testing pudendal nerve conduction in evaluating erectile dysfunction in diabetics. Int J Impot Res 12:10–105

    PubMed  CAS  Google Scholar 

  38. Francavilla S, Properzi G, Bellini C, Marino G, Ferri C, Santucci A (1997) Endothelin-1 in diabetic and non-diabetic men with erectile dysfunction. J Urol 158:1770–1774

    PubMed  CAS  Google Scholar 

  39. Garban H, Marquez D, Magee T et al Cloning of rat and human inducible penile nitric oxide synthetase application for gene therapy for erectile dysfunction. Biol. Reprod. 56 (1997) 954 - 963

    CAS  Google Scholar 

  40. Garg R, Khaishgi A, Dandona P (1999) Sildenafil for diabetic men with erectile dysfunction. JAMA 281:939–941

    Google Scholar 

  41. Gilbert P, Sparwasser C, Beckert R, Treiber U, Pust R (1992) Venous surgery in erectile dysfunction. Urol Int 49:40–47

    PubMed  CAS  Google Scholar 

  42. Giugliano D, Ceriello A (1996) Oxidative stress and diabetic vascular complications. Diabetes Care 19 /3:257–267

    PubMed  CAS  Google Scholar 

  43. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD Wicker PA, for the Sildenafil Study Group (1998) Oral Sildenafil in the treatment of erectile dysfunction. NEJM 338 /20:1397–1404

    Google Scholar 

  44. Gorek M, Stief CG, Härtung C, Jonas U (1997) Computer assisted interpretation of elec-tromyograms of corpora cavernosa using fuzzy logic. World J Urol 15:65–70

    PubMed  CAS  Google Scholar 

  45. Hakim LS, Goldstein I (1996) Diabetic sexual dysfunction. Endocrinol metab Clin North Am 25:379–400

    PubMed  CAS  Google Scholar 

  46. Harrison DG (1993) Endothelial dysfunction in the coronary microcirculation a new clinical entity or an experimental finding? J Clin Ivest 91:1–2

    CAS  Google Scholar 

  47. Hauner H, von Ferber L, Köster I (1992) Prävalenz und ambulante Versorgung insulinbehandelter Diabetiker im Alter unter 40 Jahren. Eine Analyse von Krankenkassendaten der AOK Dortmund. Diab Stoffw 5:101–106

    Google Scholar 

  48. Heaton JPW (2000) Apomorphin an update of clinical trial results. Int J Impot Res 12:[Suppl 4] 67–73

    Google Scholar 

  49. Herbault AG, Nogueira MC, Wespes E (1989) Bulbocavernosus reflex in the investigation of diabetic impotence. Br J Urol 63:332–335

    Google Scholar 

  50. Hirshkowitz M, Karacan I, Rando KC, Williams RL, Howell JW (1990) Diabetes, erectile dysfunction, and sleep related erections. Sleep 13:5–68

    PubMed  CAS  Google Scholar 

  51. Hoffmann D, Seftel AD, Hampel N, Resnick MI (1995) Advanced glycation end-products quench cavernosal nitric oxide. J Urol 153:441 A

    Google Scholar 

  52. Hosking DJ, Bennet D, Hampton JR, Evans DF, Clark AJ, Robertson G (1979) Diabetic impotence studies of nocturnal erection during REM sleep. Br Med J 2:1394–1396

    PubMed  CAS  Google Scholar 

  53. Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukuto JM, Rajfer J (1990) Nitric oxide and cyclic GMP formation upon electric field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun 170:84–850

    PubMed  CAS  Google Scholar 

  54. Jarow JP (1996) Risk factors for penile prostehtic infection. J Urol 156:402–404

    PubMed  CAS  Google Scholar 

  55. Jarow JP, DeFranzo AJ (1996) Long-term results of arterial bypass surgery for impotence secondary to segmental vascular disease. J Urol 156:982–985

    PubMed  CAS  Google Scholar 

  56. Jensen SB (1981) Diabetic sexual function a comparative study of 160 insulin treated diabetic men and women, and an aged matched controll group. Arch Sex Behav 10:49–504

    PubMed  CAS  Google Scholar 

  57. Jensen SB (1986) Sexual dysfunction in insulin treated diabetics a six year follow-up study of 101 patients. Arch Sex Behav 15:271–284

    PubMed  CAS  Google Scholar 

  58. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB (2000) Incidence of erectile dysfunction in men 40 to 69 years old longitudinal results from the Massachusetts Male Aging Study. J Urol 163:460–463

    PubMed  CAS  Google Scholar 

  59. Kadioglu A, Erdogru T, Kardisag K, Dinccag N, Satman I, Yilmaz T, Tellaloglu S (1995) Evaluation of penile arterial system with color Doppler ultrasonography in nondiabetic and diabetic males. Eur Urol 27 /4:311–314

    PubMed  CAS  Google Scholar 

  60. Kerner W (1998) Klassifikation und Diagnose des Diabetes mellitus. Dtsch Ärztebl 95 /49:3144–3148

    Google Scholar 

  61. Kim SC, Ahn SY, Park SH, LeeMY, Uhm DY (1995) A comparison of the releaxation responses of isolated cavernosal smooth muscles by endothelium-independent and endo-thelium-dependent vasodilatators in diabetic men with impotence. J Korean Med Sei 10:1–6

    CAS  Google Scholar 

  62. King H, Aubert RE, Hermann WH (1998) Global Burden of Diabetes, 1995-2025 Pre-valance, numerical estimates and projections. Diabetes Care 16:157–177

    Google Scholar 

  63. Klein R, Klein BEK, Lee KE, Moss SE, Cruickshanks KJ (1996) Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care 19 /2:135–141

    PubMed  CAS  Google Scholar 

  64. Kolodny RC, Kahn CB, Goldstein HH, Barnett DM (1974) Sexual dysfunction in diabetic men. Diabetes 23:306–309

    PubMed  CAS  Google Scholar 

  65. Köhler C, Temelkova-Kurktschiev T, Schaper F, Fucker K, hanefeld M (1999) Prävalenz von neuentdecktem Typ 2 Diabetes, gestörter Glukosetoleranz und gestörtem Nüchternglukose in einer Risikopopulation. Daten der RIAD-Studie nach Anwendung neuer Diagnosekriterien für Diabets. Dtsch Med Wochenschr 124:1057–1061

    PubMed  Google Scholar 

  66. Kuuisisto J, Mykkanen L, Pyorala K, Laakso M (1994) NIDDM and ist metabolic control predict coronary heart disease in elderly subjects. Diabetes 43:960–967

    Google Scholar 

  67. LaPorte RE, Cruickshanks KJ (1985) Incidence and risk factors for insulin dependent diabetes. In National Diabets Data Group. Diabetes in America diabetes data compiled 1984. Bethesda, Md Department of Health and Human Services, III-1-III-12 (NIH publication no. 85–1468 )

    Google Scholar 

  68. Laumann EO, Paik A, Rosen RC (1999) Sexual dysfunction in the United States. Prevalence and predictors. J Amer Med Ass 281:537–544

    CAS  Google Scholar 

  69. Lepore, Nosari I (2001) Efficacy of oral sildenafil in the treatment of erctile dysfunction in diabetic men with positive response to intracavernosal injection of alprostadil. Diabets Care 24 /2:409–411

    CAS  Google Scholar 

  70. Lewis RW, Witherington R (1997) External vacuum therapy for erectile dysfunction. World J Urol 15:78–82

    PubMed  CAS  Google Scholar 

  71. Lipshultz LI, Kim ED (1999) Treatment of erectile dysfunction inmen with diabetes. JAMA 281:465–466

    PubMed  CAS  Google Scholar 

  72. Lorenzi M, Montisano DF, Toledo S, Barrieux A (1986) High glucose induces DNA damage in cultured human endothelial cells. J Clin Invest 77:322–325

    PubMed  CAS  Google Scholar 

  73. Low PA, Tuck RR, Takeuchi M (i987)Nerve microenviroment in diabetic neuropathy. In:Dyck PJ (ed) Diabetic neuropathy. W.B. Saunders, Philadelphia, pp 266–278

    Google Scholar 

  74. Lue TF, Tanagho EA (1987) Physiology of erection and pharmacological management of impotence. J Urol 137:829–836

    PubMed  CAS  Google Scholar 

  75. Lue TF, Hricak H, Schmidt RA, Tanagho EA (1986) Functional evaluation of penile veins by cavernosography and papaverine-induced erection. J Urol 135:479–486

    PubMed  CAS  Google Scholar 

  76. Lugg JA, Rajfer J, Gonzalez-Cadavid NF (1995) The role of nitric oxide in erectile dysfunction. J Androl 16:2–5

    PubMed  CAS  Google Scholar 

  77. Lustman PJ, Clouse RE (1990) Relationsship of psychiatric illness to impotence in men with diabetes. Diabetes Care 13:89–895

    PubMed  CAS  Google Scholar 

  78. Lynch MJ, Scott GM, Inglis JA, Pryor JP (1994) Reducing the loss of implants following penile prosthetic surgery. Br J Urol 73:42–427

    PubMed  CAS  Google Scholar 

  79. Marsiglio W, Donnely D (1991) Sexual relations in later life:a national study of married persons. J Gerontol 46:338–344

    Google Scholar 

  80. McCulloch DK, Campell IW, Wu FC, Prescott RJ, Clarke BF (1980) The prevalence diabetic impotence. Diabetologia 18:279–283

    PubMed  CAS  Google Scholar 

  81. McCulloch DK, Young RJ, Prescott RJ, Campbell JW, Clarke BF (1984) The natural history of impotence in diabetic men. Diabetologia 26:437–440

    PubMed  CAS  Google Scholar 

  82. McCulloch DK, Hosking DJ, Tobert A (1986) A pragmatic approach to sexual dysfunction in diabetic men psychosexual counselling. Diabetic Med 3:485–489

    PubMed  CAS  Google Scholar 

  83. McKinlay JB (2000) The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res 12:[Suppl 4]:6–11

    Google Scholar 

  84. Melman A, Gingell JC (1999) The epidemiology and pathophysiology of erectile dysfunction. J Urol 161:5–11

    PubMed  CAS  Google Scholar 

  85. Mersdorf A, Goldsmith PC, Diederichs W, Padula C, Lue TF, Fishman IJ, Tanagho EA (1991) Ultrastructural changes in impotent penile tissue. A comparison of 65 patients. J Urol 145:749–758

    PubMed  CAS  Google Scholar 

  86. Michaelis D, Jutzi E (1991) Epidemiologie des Diabetes mellitus in der Bevölkerung der ehemaligen DDR:Alters- und geschlechtsspezifische Inzidenz- und Prävalenztrends im Zeitraum 1960-1987. Z Klin Med 46:59–64

    Google Scholar 

  87. Miller MAW, Morgan RJ, Thompson CS, Mikhailidis DP, Jeremy JY (1994) Adenylate and guanylate cyclase activity in the penis and aorta of the diabetic rat an in vitro study. Br J Urol 74:106–111

    PubMed  CAS  Google Scholar 

  88. Miller MAW, Morgan RJ, Thompson CS, Mikhailidis DP, Jeremy JY (1994) Hydrolysis of cyclic guanosine monophosphate and cyclic adenosine monophosphate in the penis and aorta of diabetic rats. Br J Urol 74:252–256

    Google Scholar 

  89. Montague DK, Barada JK, Belker AM et al. (1996) Clinical guidelines panel on erectile dysfunction summary report on the treatment of organic erectile dysfunction. J Urol 156 2007–2011

    PubMed  CAS  Google Scholar 

  90. Moody JA, Vernet D, Laidlow S, Rajfer J, Gonzalez-Cadavid N (1997) Effect of long-term oral administration of 1-arginine on the rat erectile response. J Urol 158:942–947

    PubMed  CAS  Google Scholar 

  91. National Institutes of Health, National Institute of Diabets and Digestive and Kidney Diseases (1995) Diabetes in America. 2nd ed. NIH Publ No 95–1468

    Google Scholar 

  92. National Insitutes of Health Consensus Development (1993) Panel on Impotence. JAMA 270:8–90

    Google Scholar 

  93. Padma-Nathan H, Hellstrom WJG, Kaiser FE et al. (1997) Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med 366 /1:1–7

    Google Scholar 

  94. Palitzsch K-D, Nusser J, Arndt H et al. (1999) Die Prävalenz des Diabets mellitus wird in Deutschland deutlich unterschätzt - eine bundesweite epidemiologische Studie auf der Basis einer HbA1c-Analyse. Diabetes Stoffwechsel 8:189–200

    Google Scholar 

  95. Parrazini F, Fabris FM, Bortolotti A et al. (2000) Frequency and determinants of erectile dysfunction in Italy. Eur Urol 37:4–49

    Google Scholar 

  96. Parys BT, Evans CM, Parson KF (1988) Bulbocavernosus reflex latency in the investigation of diabetic impotence. Br J Urol 61:59–62

    PubMed  CAS  Google Scholar 

  97. Pfeiffer E, Verwoerdt A, Wang HS (1968) Sexual behavior in aged men and women. Arch Gen Psychiatr 19:735–758

    Google Scholar 

  98. Pieper GM, Dondlinger LA (1997) Plasma and vascular tissue arginine are decreased in diabetes acute arginin supplementation restores endothelium-dependent relaxation by augmenting cGMP production. J Pharmacol Exp Ther 283:684–691

    PubMed  CAS  Google Scholar 

  99. Porst H (1996) The rationale for prostaglandin E1 in erectile failure A survey of world¬wide experience. J Urol 155:802–815

    PubMed  CAS  Google Scholar 

  100. Porst H (1997) Transurethral Alprostadil with MUSE™ (medicated urethral system for erection) vs intracavernous Alprostadil - a comparative study in 103 patients with erectile dysfunction. Int J Impot Res 9:187–192

    PubMed  CAS  Google Scholar 

  101. Price DE, Cooksey G, Jehu D, Bentley S, Hearnshaw JR, Osborn DE (1991) The mangement of impotence in diabetic men by vacuum tumescence therapy. Diabetic Med 8:964–967

    PubMed  CAS  Google Scholar 

  102. Price DE, O’Malley BP, James M, Roshan M, Hearnshaw JR (1991) Why are impotent diabetic men not being treated? Practic Diabetes 8:10–11

    Google Scholar 

  103. Rajfer J, Aronson WJ, Bush P, Dorey FJ, Ignarro LJ (1992) Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 326:90–94

    PubMed  CAS  Google Scholar 

  104. Reichel G, Neundörfer B (1996) Pathogenese und Therapie der peripheren diabetischen Polyneuropathien. Dtsch Ärztebl 93 /15:96–968

    Google Scholar 

  105. Rendell MS, Raijfer J, Wicker PA et al. (1999) Sildenafil for treatment of erectile dysfunction in men with diabetes. Arandomized controll trial. Sildenafil Diabetes Study Group. JAMA 281:421–426

    PubMed  CAS  Google Scholar 

  106. Romeo JH, Seftel Ad, Madhun ZT, Aron DC (2000) Sexual function in men with diabetes type 2 Association with glycemic control. J Urol 163:788–791

    PubMed  CAS  Google Scholar 

  107. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Dysfunction (IIEF-5) as a diagnostic tool for erctile dysfunction. Int J Impot Res 11:319–326

    PubMed  CAS  Google Scholar 

  108. Ryder REJ, Marshall R, Johnson K, Ryder AP, Owens DR, Hayes TM (1988) Acetylcholine sweatspot test for autonomic denervation. Lancet i:130–1305

    Google Scholar 

  109. Saenz de Tejada IS, Goldstein I, Azadzoi K, Krane RJ, Cohen RA (1989) Impaired neuro¬genic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 320:1025–1030

    PubMed  CAS  Google Scholar 

  110. Sarica Y, Karucan I (1987) Bulbocavernosus reflex to somatic and visceral nerve stimulation in normal subjects and in diabetics with erectile impotence. J Urol 138:55–58

    PubMed  CAS  Google Scholar 

  111. Scherbaum WA, Lauterbach KW, Joost HG (Hrsg) (2001) Definition, Klassifikation und Diagnostik des Diabetes mellitus. Evidenzbasierte Diabetes-Leitlinien DDG 2000 /2001

    Google Scholar 

  112. Schultheiss D, Truss MC, Becker AJ, Stief CG, Jonas U (1997) Dorsale Penisvenenligatur (DPVL) - Prognostische Faktoren und Langzeitresultate. Urologe A 36:351–355

    PubMed  CAS  Google Scholar 

  113. Schultheiss D, Truss MC, Becker AJ, Stief CG, Jonas U (1997) Long-term results following dorsal penile vein ligation in 126 patients with venoocclusive dysfunction. Int J Impot Res 9:205–209

    PubMed  CAS  Google Scholar 

  114. Seftel AD, Vaziri ND, Ni Z et al. (1997) Advanced glycation end products in human penis elevation in diabetic tissue, site of deposition, and possible effects trough iNOS or eNOS. Urology 50:1016–1026

    PubMed  CAS  Google Scholar 

  115. Shabsigh R (1997) The effects of testosterone on the cavernous tissue and erectilefunc-tion. World J Urol 15:21–26

    PubMed  CAS  Google Scholar 

  116. Sharaby JS, Benet AE, Melman A (1995) Penile revascularization. Urol Clin NA 22 /4:821–832

    CAS  Google Scholar 

  117. Shirai M, Takanama M, Tanaka T, Matsumashi M, Maki A, Niura K, Ando K (1987) A stochastic survey of impotence population in Japan. Impotence 2:67–93

    Google Scholar 

  118. Simopoulos DN, Gibbons SJ, Malysz J et al. (2001) Corporal structural and vascular microarchitecture with x-ray micro computerized tomography in normal and diabetic rabbits histopathological correlation. J Urol 165:1776–1782

    PubMed  CAS  Google Scholar 

  119. Singer DE, Nathan DM, Anderson KM, Wilson PWF, Evans JC (1992) Association of HbAic with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 41:202–208

    PubMed  CAS  Google Scholar 

  120. Smith SA, Dewhirst RR (1986) A simple diagnostic test for pupillary abnormality in diabetic autonomic neuropathy. Diabet Med 3:38–41

    PubMed  CAS  Google Scholar 

  121. Solstad K, Hertoft P (1993) Frequency of sexual problems and sexual dysfunction in middle-aged Danish men. Arch Sex Behav 22:51–58

    PubMed  CAS  Google Scholar 

  122. Spector KR, Boyle M (i986)The prevalence and perceived aetiology of male sexual problems in a non-clinical sample. Br J Med Psychol 59:351–358

    Google Scholar 

  123. Stief CG, Djamilian M, Schaebsdau F et al. (1990) Single potential analysis of cavernous electrical activity. A possible diagnosis of autonomic impotence. World J Urol 8:75–81

    Google Scholar 

  124. Stief CG, Wetterauer U, Schaebsdau F, Jonas U (1991) Calcitonin-gene related peptide a possible neurotransmitter in human penile erection. J Urol 146:1010–1014

    PubMed  CAS  Google Scholar 

  125. Stief CG, Djamilian M, Truss MC, Tan H, Thon WF, Jonas U (1994) Prognostic factors for the postoperative outcome of penile venous surgery for venogenic erectile dysfunction. J Urol 151:880–883

    PubMed  CAS  Google Scholar 

  126. Sullivan ME, Dashwood MR, Thompson CS, Muddle JR, Mikhailidis DP, Morgan RJ (1997) Alterations in endothelin B receptor sites in cavernosal tissue of diabetic rabbits potential relevance to the pathogenesis of erectile dysfunction. J Urol 158:1966–1972

    PubMed  CAS  Google Scholar 

  127. Sullivan ME, Keoghane SR, Miller MAW (2001) Vascular risk factors and erectile dysfunction. BJU Int 87:838–845

    PubMed  CAS  Google Scholar 

  128. Takahashi K, Ghatei MA, Lam H-C, O’Halloran DJ, Bloom SR (1990) Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 33:306–310

    PubMed  CAS  Google Scholar 

  129. Tesfamariam B, Kakubowski JA, Cohen RA (1989) Contraction of diabetic rabbit aorta caused by endothelium-derived PGH2-TXA2. Am J Physiol 265:219–225

    Google Scholar 

  130. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 329:977–986

    Google Scholar 

  131. The Expert Committee On The Diagnosis Ans Classification OF Diabetes Mellitus (2000) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 23 [Suppl 1]:4–19

    Google Scholar 

  132. Truss MC, Becker AJ, Schultheiss D, Jonas U (1997) Intracavernous pharmacotherapy. World J Urol 15:71–77

    PubMed  CAS  Google Scholar 

  133. Tsai YS, Lin JSN, Lin YM (2000) Safety and efficacy of alprostadil sterile (s. po, Caver- ject®) in diabetic patients with erectile dysfunction. Eur Urol 38:177–183

    PubMed  CAS  Google Scholar 

  134. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of com-plications in patients with typ 2 diabetes (UKPDS 33). Lancet 352:837–853

    Google Scholar 

  135. UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with typ 2 diabetes (UKPDS 34). Lancet 352:854–865

    Google Scholar 

  136. Uuisitupa MIJ, Niskanen LK, Siitonen O, Vouitilainen E, Pyorala K (1993) Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin dependent) diabetic and non-diabetic subjects. Diabetologia 36:1175–1184

    Google Scholar 

  137. Vardi Y, Sprecher E, Gruenwald I (2000) Logistic regression and survival analysis of 450 impotent patients treated with injection therapy long-term dropout parameters. J Urol 163:467–470

    PubMed  CAS  Google Scholar 

  138. Veves A, Webster L, Chen TF, Payne S, Boulton AJ (1995) Aetiopathogenesis and mangement of impotence in diabetic males four years experience from acombined clinic. Diabet Med 12 /1:77–82

    PubMed  CAS  Google Scholar 

  139. Von Ferber L, Salzsieder E, Hauner H et al. (1993) Diabetes prevalence from health insurance data evaluation of estimates by comparison with a population based diabetes register. Diabet Metab 19:89–95

    Google Scholar 

  140. Vrijhof HJ, Delaere KP (1994) Vacuum constriction devices in erectile dysfunction acceptance and effectiveness in patients with impotence of organic or mixed aetiology. Br J Urol 74 /1:102–105

    PubMed  CAS  Google Scholar 

  141. Wilson SK, Delk JRII (1995) Inflatable penile implant infection predisposing factors and treatment suggestions. J Urol 153:659–661

    PubMed  CAS  Google Scholar 

  142. Yarnitsky D, Sprecher E, Vardi Y (1996) Penile thermal sensation. J Urol 156:391–393

    PubMed  CAS  Google Scholar 

  143. Ziegler D (1994) Diagnosis, staging, epidemiology of diabetic peripheral neuropathy. Diabet Nutri Metab 7:342–348

    Google Scholar 

  144. Ziegler D, Gries FA (1996) Diabetische Neuropathie. Klassifikation, Epidemiologic, Prognose und sozialmedizinische Bedeutung. Dtsch Arztebl 93 /11:680–684

    Google Scholar 

  145. Zonszein J (1995) Diagnosis and management of endocrine disorders of erectile dys-function. Urol Clin North Am 22 /4:789–802

    PubMed  CAS  Google Scholar 

  146. Zorgniotti AW, Lizza EF (1994) Effect of large doses of the nitric oxide precursor,L-Ar-ginine, on ercectile dysfunction. Int J Impot Res 6:33

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. P. Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. P. Jünemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Derouet
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. H. Jost
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Ückert
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Küthe
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. G. Stief
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G. Popken
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. U. Wetterauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. H. M. Behre
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. U. Hartmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. W. F. Thon
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. A. Thon
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Urologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Germany

    C. G. Stief , M. C. Truss  & U. Jonas ,  & 

  2. Arbeitsbereich Klinische Psychologie, Zentrum Psychologische Medizin Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Germany

    U. Hartmann

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schmidt, P. et al. (2002). Anatomie, Physiologie, Pathophysiologie. In: Stief, C.G., Hartmann, U., Truss, M.C., Jonas, U. (eds) Zeitgemäße Therapie der erektilen Dysfunktion. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59392-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59392-5_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-42443-7

  • Online ISBN: 978-3-642-59392-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation